HemaSphere
(Aug 2023)
S313: HEALTH ECONOMIC EVALUATION OF THIRD-LINE INTERVENTIONS FOR TRANSPLANT-INELIGIBLE RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN GERMANY
- Melina Sophie Kurte,
- Ann-Cathrine Siefen,
- Anna Marie Bauer,
- Hans Christian Reinhardt,
- Florian Kron
Affiliations
- Melina Sophie Kurte
- 1 University of Duisburg-Essen, Faculty of Medicine, Essen, Germany
- Ann-Cathrine Siefen
- 2 VITIS Healthcare Group, Cologne, Germany
- Anna Marie Bauer
- 2 VITIS Healthcare Group, Cologne, Germany
- Hans Christian Reinhardt
- 1 University of Duisburg-Essen, Faculty of Medicine, Essen, Germany
- Florian Kron
- 2 VITIS Healthcare Group, Cologne, Germany
- DOI
-
https://doi.org/10.1097/01.HS9.0000968164.63952.98
- Journal volume & issue
-
Vol. 7
p.
e6395298
WeChat QR code